Medytox Receives Product Approval in Colombia for Three Types of Attier HA Fillers
Accelerating Expansion in the Latin American Market
Medytox announced on September 2 that it has received product approval from Colombia's National Food and Drug Surveillance Institute (INVIMA) for three types of hyaluronic acid fillers: 'Attier Classic,' 'Intensive,' and 'Volume.'
Colombia, known for its excellent medical services and strong demand for aesthetic medicine, is a key market in the Latin American aesthetic industry. Following Brazil and Mexico, it has formed the third largest medical device market in the region.
Medytox stated, "With this approval, we have established an aesthetic portfolio in Colombia encompassing hyaluronic acid fillers such as Neuramis and Attier, as well as the botulinum toxin product Meditoxin. By building a foundation to proactively meet the diverse procedural needs of local medical professionals, we expect to further strengthen our competitiveness in the market."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Medytox also plans to continue expanding its presence in neighboring Latin American countries, centered on Colombia, to broaden its global influence.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.